The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies

Weihu Shang,Weidong Lu,Mei Han,Jinping Qiao
DOI: https://doi.org/10.2174/1871520614666140829123651
IF: 2.8
2014-01-01
Anti-Cancer Agents in Medicinal Chemistry
Abstract:Tea catechins exhibit a broad range of pharmacological activities that impart beneficial effects on human health. Epigallocatechin-3-gallate (EGCG), one of the major tea catechins, has been widely associated with cancer prevention and treatment. In addition, tea catechins in combination with anticancer drugs are being evaluated as a new cancer treatment strategy. However, the interactions of anticancer drugs with tea catechins are largely unknown. Accumulated data indicate significant interactions between anticancer drugs and tea catechins, such as synergistic tumor inhibition or antagonist activity. Therefore, it is critical to understand comprehensively the effects of tea catechins on anticancer drugs. Focusing on evidence from preclinical studies, this paper will review the interactions between anticancer drugs and tea catechins, including pharmacodynamics and pharmacokinetics effects. We hope that by detailing the interactions between anticancer drugs and tea catechins, more attention will be directed to this important therapeutic combination in the future.
What problem does this paper attempt to address?